Cargando…
SARS-CoV-2 Virus Manifestations in the Gastrointestinal Tract: Therapeutic Implications
BACKGROUND: About 1 year ago a novel virus − SARS-CoV-2 − began to spread around the world. It can lead to the disease COVID-19, which has caused more than 1 million deaths already. SUMMARY: While it was first recognized as a disease leading to pneumonia and lung failure, we know by now that COVID-1...
Autores principales: | Jefremow, André, Neurath, Markus F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger GmbH
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802000/ https://www.ncbi.nlm.nih.gov/pubmed/33693046 http://dx.doi.org/10.1159/000513180 |
Ejemplares similares
-
CRISPR/Cas9 in Gastrointestinal Malignancies
por: Jefremow, André, et al.
Publicado: (2021) -
All are Equal, Some are More Equal: Targeting IL 12 and 23 in IBD – A Clinical Perspective
por: Jefremow, André, et al.
Publicado: (2020) -
Novel Small Molecules in IBD: Current State and Future Perspectives
por: Jefremow, André, et al.
Publicado: (2023) -
Gastrointestinal manifestations and SARS-CoV-2 infection
por: Pizuorno, Antonio, et al.
Publicado: (2021) -
SARS-CoV-2 and the Gastrointestinal Tract in Children
por: Puoti, Maria Giovanna, et al.
Publicado: (2021)